258 related articles for article (PubMed ID: 12024771)
1. Drug-altered states. As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costs.
Tieman J
Mod Healthc; 2002 Apr; 32(17):28-31. PubMed ID: 12024771
[No Abstract] [Full Text] [Related]
2. States combat drug costs.
Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442
[No Abstract] [Full Text] [Related]
3. Pharmaceuticals: pharmaceutical cost control measures: year end report-2002.
Kammer C
Issue Brief Health Policy Track Serv; 2002 Dec; ():1-14. PubMed ID: 12856689
[No Abstract] [Full Text] [Related]
4. Rx for Medicaid: with Medicaid costs rising and revenues declining, states are looking at what to do.
Tobler L; Folkemer D
State Legis; 2003 Apr; 29(4):16-20. PubMed ID: 12678012
[No Abstract] [Full Text] [Related]
5. Expenditures for prescription drugs: too much or not enough?
Schumock GT; Walton SM
Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
Seay M; Varma P
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
[TBL] [Abstract][Full Text] [Related]
7. Confronting costs: Medicaid spending is at the top of many legislative agendas.
Hansen M
State Legis; 2012 Jun; 38(6):30-2. PubMed ID: 22730577
[No Abstract] [Full Text] [Related]
8. Limits on Medicare's ability to control rising spending on cancer drugs.
Bach PB
N Engl J Med; 2009 Feb; 360(6):626-33. PubMed ID: 19176475
[No Abstract] [Full Text] [Related]
9. [Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities].
Andreasen J
Ugeskr Laeger; 2003 Jul; 165(29):2873-6. PubMed ID: 12908355
[No Abstract] [Full Text] [Related]
10. Pharmaceutical reimbursement and drug cost control: the MAC experience in Maryland.
Sawyer DO
Inquiry; 1983; 20(1):76-87. PubMed ID: 6219949
[TBL] [Abstract][Full Text] [Related]
11. Managing Medicaid drug expenditures.
Sudovar SG; Rein SD
J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
[No Abstract] [Full Text] [Related]
12. Medicaid's new prescription drug legislation: prudent purchasing and drug use review.
Coster JM
Alaska Med; 1991; 33(4):147-50. PubMed ID: 1816731
[No Abstract] [Full Text] [Related]
13. Drugs still influence health costs, but trend abating.
Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
[No Abstract] [Full Text] [Related]
14. Medicaid rescue effort to be 'painful'. Interview by Bob Carlson.
Verdier J
Indiana Med; 1993; 86(2):134-41. PubMed ID: 8463642
[No Abstract] [Full Text] [Related]
15. Plans confront specialty pharmacy's escalating costs in variety of ways.
Reinke T
Manag Care; 2010 Dec; 19(12):12-3, 15-6, 19. PubMed ID: 21291126
[No Abstract] [Full Text] [Related]
16. Pharmaceuticals issue brief: pharmaceuticals cost control: year end report--2004.
Seay M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-17. PubMed ID: 15724308
[No Abstract] [Full Text] [Related]
17. Dual costs. Feds, states focus on ways to improve care and rein in spending for high-cost patients eligible for both Medicaid and Medicare.
Daly R
Mod Healthc; 2012 May; 42(19):28-30. PubMed ID: 22670270
[No Abstract] [Full Text] [Related]
18. Missouri Medicaid reform...what can physicians do?
Halverson LW
Mo Med; 2006; 103(2):102-5. PubMed ID: 16703704
[No Abstract] [Full Text] [Related]
19. These doctor's mission: keeping drug costs down.
Guglielmo WJ
Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
[No Abstract] [Full Text] [Related]
20. Study shows increases in drug costs may be justified by improvements in outcomes.
Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
